Supplementary Figure Legend from Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
Cory Allen(Mayo Clinic), Evanthia Galanis(Mayo Clinic in Arizona), Joon H. Uhm(Mayo Clinic), C. David James, Stephen J. Russell(University of Minnesota Rochester), James Krempski(University of North Carolina at Chapel Hill), Caterina Giannini(Mayo Clinic), Takafumi Nakamura(Tottori University), Kah-Whye Peng(University of Minnesota Rochester), Roberto Cattaneo(Mayo Clinic in Arizona), Jenny M. Goble(Mayo Clinic), Mark A. Schroeder(MACOM (United States)), Sompong Vongpunsawad(Mayo Clinic)
Cited by 0
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
|Journal of Clinical Oncology|2005|695
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
|Neuro-Oncology|2015|670